Krystal Biotech Inc
NASDAQ:KRYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
L
|
LY Corp
XMUN:YOJ
|
JP |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
Aviva PLC
LSE:AV
|
UK |
|
Conduent Inc
NASDAQ:CNDT
|
US |
|
Community Health Systems Inc
NYSE:CYH
|
US |
|
Basic Fit NV
AEX:BFIT
|
NL |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
Kenedix Office Investment Corp
TSE:8972
|
JP |
|
UWM Holdings Corp
NYSE:UWMC
|
US |
|
Mitsubishi Chemical Holdings Corp
TSE:4188
|
JP |
|
TC Energy Corp
TSX:TRP
|
CA |
|
D
|
Distell Group Holdings Ltd
JSE:DGH
|
ZA |
|
I
|
Invincible Investment Corp
TSE:8963
|
JP |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
Palantir Technologies Inc
NASDAQ:PLTR
|
US |
|
Shurgard Self Storage Ltd
XBRU:SHUR
|
GG |
|
Marchex Inc
NASDAQ:MCHX
|
US |
|
P
|
Pepkor Holdings Ltd
JSE:PPH
|
ZA |
Wall St Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for KRYS is 315.49 USD with a low forecast of 217.15 USD and a high forecast of 418.95 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KRYS's stock price target?
Price Target
315.49
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 315.49 USD with a low forecast of 217.15 USD and a high forecast of 418.95 USD.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 7 years is 16%.
